TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

newsBanner

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

Q&A with Philippe Deschamps, President, Chairman and CEO of Helius Medical Technologies, Inc. releasing Registrational Trial Data for their Portable Neuromodulation Stimulator, PoNS™ Device showing ability to help Patients Recover from Balance Disorder caused by Traumatic Brain Injury

| DEC 04, 2017

Helius Announces Positive Results from Portable Neuromodulation Stimulator Trial

| NOV 22, 2017

Good Money No Longer Goes To Die In Neuroscience

| OCT 23, 2017

Grateful Patients Turn The Spotlight On You!

| SEP 29, 2017

Helius Medical extends U.S. Army contract, looks to future of portable neuromod

| NOV 22, 2016

Helius Medical Technologies’ CEO and Co-Founder – BNN Interview at the Toronto Stock Exchange

| JUN 17, 2016

Helius Medical Technologies, Inc. and CEO – Phil Deschamps featured in CEO/CFO Magazine

| FEB 15, 2016

Helius’ PoNS Technology Named in Top 10 Multiple Sclerosis Articles of 2015

| JAN 02, 2016

Making the Tongue-Brain Connection: Helius’ neuromodulation technology meets endpoints in MS pilot study

| NOV 03, 2015

Helius Medical Technologies Featured in Forbes – Is Your Tongue The Key To A Neuroscience Breakthrough?

| NOV 02, 2015

Philadelphia Business Journal: Medical-device firm developing brain healing technology raises $2 million

| OCT 27, 2015

Helius highlighted in Philadelphia Business Journal

PHILADELPHIA BUSINESS JOURNAL | JUN 01, 2015

Helius CEO featured in medtech startup article

MASS DEVICE | JUN 01, 2015

Helius Featured on Company Execs Online ‘CEO Clips’

BUSINESS TELEVISION | MAY 11, 2015

Mouth device in clinical trials as possible treatment for TBI

US ARMY | FEB 14, 2013

Activating the brain

AMERICAN WAY | JUL 15, 2010